| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a48f7041ccb8f13d812f43c4478a3e60 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
| filingDate |
2022-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcfbd205d3280e4b6df94be19cf8b707 |
| publicationDate |
2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114931568-A |
| titleOfInvention |
A kind of medicine for treating male prostatitis and application thereof |
| abstract |
The invention discloses a medicine for treating male prostatitis, comprising composition A and composition B, wherein the composition A comprises 2-8 parts of medical distilled water and 2-8 parts of lidocaine injection, so The composition B comprises 80-120 parts of levofloxacin injection and 8-12 parts of medical glucose powder, and the concentration of the levofloxacin is 0.2%. The invention can be used for the treatment of prostatitis syndrome, has high cure rate and low recurrence rate, and can be widely used in the technical field of male disease medicine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115721607-A |
| priorityDate |
2022-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |